UK Pharma Stocks Fall as Trump Repeals Obamacare

Shares in UK pharmaceutical companies were under pressure last week, after Trump signed an order scaling back parts of Obamacare. Ketan Patel, fund manager at EdenTree talks to Morningstar, telling the publication that Trump’s pledge to relax regulations will bring greater risk for patients, pharmaceutical companies and the wider healthcare system.